BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Bausch Health Companies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$6.32+0.02 (+0.32%)
Close on Oct 19, 2026
- Market cap
- $2.39B
- P/E (TTM)
- –
- Dividend yield
- –
Bausch Health Companies statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Market Cap | $2.36B | $197.05M |
| Enterprise Value | $22.25B | $106.56M |
| PS Ratio | 0.22 | 3.93 |
| P/FCF Ratio | 1.65 | 18.25 |
| P/OCF Ratio | 1.31 | 13.78 |
Enterprise value
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| EV / Sales | 2.05 | 2.69 |
| EV / EBITDA | 10.83 | 14.86 |
| EV / EBIT | 25.20 | 19.00 |
| EV / FCF | 15.55 | 21.02 |
Income (trailing twelve months)
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Revenue | $10.85B | $57.94M |
| Operating Income | $883.00M | -$21.44M |
| Pretax Income | -$732.00M | -$14.45M |
| Net Income | -$1.10B | -$22.46M |
| EBITDA | $2.06B | -$16.91M |
| EPS (Diluted) | -$2.96 | -$0.83 |
Margins
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Operating Margin | 8.14% | -44.5% |
| Pretax Margin | -6.74% | -13.0% |
| Profit Margin | -10.1% | -39.2% |
| EBITDA Margin | 18.9% | -31.3% |
| FCF Margin | 13.2% | -8.85% |
Returns
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Return on Assets (ROA) | -4.22% | -41.0% |
| Return on Invested Capital (ROIC) | 3.83% | -32.0% |
| Return on Capital Employed (ROCE) | 4.36% | -37.8% |
Growth
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 10.1% | 6.01% |
| Net Income Growth (YoY) | -1220.4% | -37.7% |
| EPS Growth (YoY) | -1238.5% | -29.2% |
| FCF Growth (YoY) | 28.3% | 2.34% |
| Revenue Growth (3Y CAGR) | 8.11% | 2.25% |
| Revenue Growth (5Y CAGR) | 5.04% | 6.42% |
Balance sheet
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.83B | $62.42M |
| Total Debt | $20.74B | $120.13M |
| Net Cash (Debt) | -$18.92B | $15.68M |
| Net Cash Per Share | -$50.58 | $0.65 |
| Equity (Book Value) | -$1.77B | $48.79M |
| Book Value Per Share | -$4.74 | $1.36 |
| Tangible Book Value | -$15.74B | $23.06M |
| Working Capital | $1.98B | $75.77M |
Financial position
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Current Ratio | 1.44 | 3.30 |
| Quick Ratio | 0.90 | 2.39 |
| Debt / EBITDA | 10.09 | 3.35 |
| Debt / FCF | 14.49 | 5.05 |
| Net Debt / EBITDA | 9.20 | 2.22 |
| Interest Coverage | 0.55 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Operating Cash Flow | $1.80B | -$12.35M |
| Capital Expenditures | -$369.00M | -$1.06M |
| Free Cash Flow | $1.43B | -$20.28M |
| FCF Per Share | $3.83 | -$0.41 |
Efficiency
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Asset Turnover | 0.42 | 0.38 |
| Revenue Per Employee | $534.63K | $398.96K |
| Profits Per Employee | -$54.09K | -$732.08K |
| Employee Count | 20,300 | 73 |
Dividends and yields
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Earnings Yield | -46.5% | -21.2% |
| FCF Yield | 60.5% | -7.64% |
Shares
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Shares Outstanding | 373,991,000 | 59,128,900 |
| Shares Change (YoY) | 1.63% | 11.1% |
| Shares Change (QoQ) | 0.12% | 0.54% |
| Float | 256,201,000 | 48,744,500 |
| Shares Held by Insiders | 31.5% | 11.8% |
| Shares Held by Institutions | 63.4% | 59.4% |
Taxes
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Income Tax | $361.00M | $91.50K |
Scores
| Measure | Bausch Health Companies | Industry median |
|---|---|---|
| Altman Z-Score | 0.09 | 0.10 |
| Piotroski F-Score | 6 | 4 |
Calculated by StockData from Bausch Health Companies's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.